Trial Site Detail

 

Drug:
Regorafenib (BAY 73-4506)
Trial:
Phase I Study of BAY73-4506 in Chinese Patients With Advanced, Refractory Solid Tumors
Conditions: Solid Tumors
Trial Status:
Ongoing, but not recruiting

 

Site name unknown - Shatin

     
Shatin , New Teritories
Hong Kong

 

Principal Investigator:
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Site name unknown - Shatin Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.